Three Kidney Transplants, Weight Gain and a Journey Back to Wellness
Cedars-SinaiRowena Roque, 46, was having a problem that many people can relate to: doing everything in her power to lose weight and get healthy but never succeeding.
Rowena Roque, 46, was having a problem that many people can relate to: doing everything in her power to lose weight and get healthy but never succeeding.
Learn about the latest research breakthroughs and faculty updates at Cedars-Sinai for February 2023.
Experts from the Smidt Heart Institute at Cedars-Sinai, California’s premier cardiology and heart surgery provider, will present innovative research findings and lead discussions on the latest high-impact medical breakthroughs during the American College of Cardiology (ACC) Annual Scientific Session & Expo March 4-6 in New Orleans.
Elizabeth Hinlein is freshly home from three weeks in Italy. The streets of Venice, Florence, Rome and Siena inspired her creative work as an artist and filmmaker, and also helped her regain her strength and build back her stamina. And count her lucky stars.
Nicholas Tatonetti, PhD, an expert in biomedical data science, has joined Cedars-Sinai as the vice chair of Computational Biomedicine and associate director for Computational Oncology at Cedars-Sinai Cancer.
Her husband and their five children call Rosa Wernher "the Energizer bunny" because she is always on the go. For decades, not even her genetically inherited Marfan syndrome could keep her off her feet to prevent her from oil painting or from gliding down a ski slope--until it did.
Rebecca Schneyer, MD, has received the Medstar National Center for Advanced Pelvic Surgery Diversity and Inclusion Award given by the Foundation of the AAGL.
Cedars-Sinai investigators found that women who developed mood and anxiety disorders associated with pregnancy and childbirth had specific altered proteins circulating in their bloodstream in the third trimester. The study is published in the American Journal of Obstetrics & Gynecology.
Leqembi, Recientemente Aprobado por la FDA, Muestra un Beneficio Potencial para los Pacientes con Enfermedad en Etapa Temprana, pero la Disponibilidad Llevará tiempo, Comenta Experta de Cedars-Sinai
Eduardo Marbán, MD, PhD, Eugenio Cingolani, MD, y Hasan Jilaihawi, MD, presentarán avances en tratamientos y procedimientos en cardiología a los asistentes a uno de los principales congresos de cardiólogos de México.
Every day for six weeks, Neil Wank, a 26-year Los Angeles Police Department veteran who in December was diagnosed with an aggressive type of brain cancer called glioblastoma, was escorted down the long hallway leading to the Cedars-Sinai Cancer radiation therapy facility by his wife, Nikki, and 10 to 20 of his fellow officers.
Internationally recognized cardiologist in heart transplantation Jon Kobashigawa, MD, director of Advanced Heart Disease and the Heart Transplant Program in the Smidt Heart Institute at Cedars-Sinai, and chief medical officer of the California Heart Center Foundation, an affiliate of Cedars-Sinai, has been selected to receive the highly coveted 2023 Lifetime Achievement Award from the International Society for Heart and Lung Transplantation (ISHLT).
Marking the five-year anniversary of the $50 million gift that named the Smidt Heart Institute, Cedars Sinai is highlighting major research breakthroughs and clinical innovations pioneered by one of the nation’s leading destinations for cardiac care.
Investigators in the Smidt Heart Institute at Cedars-Sinai have confirmed that people who have had COVID-19 have an increased risk for new-onset diabetes—the most significant contributor to cardiovascular disease.
In a large-scale nationwide study, investigators from Cedars-Sinai Cancer have confirmed that rates of pancreatic cancer are rising—and are rising faster among younger women, particularly Black women, than among men of the same age. Their work was published today in the peer-reviewed journal Gastroenterology.
A new Cedars-Sinai study in collaboration with the University of California, Irvine (UCI) and the Answer ALS consortium has examined the expression of thousands of genes in stem cell generated motor neurons that are known to die in patients with amyotrophic lateral sclerosis, a fatal neurological disorder known as ALS or Lou Gehrig's disease.
As the nation continues to recognize American Heart Month, the Smidt Heart Institute’s Ruchira Garg, MD, director of Congenital Noninvasive Cardiology in the Guerin Family Congenital Heart Program at Cedars-Sinai, and Susanna Tran, MD, sat down with the Cedars-Sinai Newsroom to spotlight specialized fetal imaging.
Many think of epilepsy, a neurological disorder affecting 3.4 million Americans, as a chronic condition marked by occasional seizures. But the disease can be deadly, so it is essential for patients to get their seizures under control with proper treatment, said Lisa Bateman, MD, director of the Cedars-Sinai Health System Surgical Epilepsy Program.
Cedars-Sinai Health System contributed $15.4 billion in economic benefit to Southern California in fiscal year 2021 by creating and supporting tens of thousands of jobs, fueling major construction spending and assisting numerous community benefit programs across the Los Angeles region, according to a new analysis.
Experts from the Barbra Streisand Women’s Heart Center in the Smidt Heart Institute at Cedars-Sinai are available for interviews to commemorate the 18th-annual Linda Joy Pollin Women’s Heart Health Day, Feb. 3.
Cedars-Sinai has appointed leading urologic oncologist, surgeon and research investigator Hyung Kim, MD, as the inaugural chair of the newly established Department of Urology.
High-risk pregnancy specialists from Cedars-Sinai will be among an international group of investigators sharing new research at the 43rd Annual Pregnancy Meeting of the Society for Maternal-Fetal Medicine (SMFM). The conference takes place in San Francisco, Feb. 6-11, with the scientific sessions, including oral and poster presentations, beginning Thursday, Feb. 9.
Cedars-Sinai Cancer investigators have developed a new nanotechnology-based test that can detect and profile prostate cancers—even in microscopic amounts.
Physician-scientists from the Comprehensive Stroke Center at Cedars-Sinai are available to discuss the latest news and research being shared at the International Stroke Conference Feb. 8-10 in Dallas.
Heart rhythm disorders like atrial fibrillation and sudden cardiac arrest have made headlines in recent months, prompting many to learn more about how the heart beats.
A roundup of the latest medical discoveries and faculty news at Cedars-Sinai.
Heart disease is the leading cause of death among women in the U.S., and a type of heart attack called myocardial infarction with non-obstructive coronary arteries (MINOCA), which predominantly affects women, is garnering increased attention.
The annual incidence of sports-related sudden cardiac arrest in older adults is rare: 2 to 3 cases per 100,000 people.
Two novel research studies from Cedars-Sinai move the needle on predicting two important heart conditions—sudden cardiac arrest, which is often fatal, and increased coronary artery calcium, a marker of coronary artery disease that can lead to a heart attack.
Detrás de la sonrisa contagiosa de la enfermera ortopédica Paulina Andujo se encuentra no solo una cuidadora compasiva sino también un talento único.
The Cedars-Sinai Department of Biomedical Sciences has established a new division that is charged with developing a deeper understanding of the impact of social, behavioral and environmental risk factors on human diseases.
Cardiologists and surgeons from the Smidt Heart Institute at Cedars-Sinai are available for interviews during Heart Month on an array of cardio-related topics.
The Cedars-Sinai International team will participate in Arab Health, Jan. 30-Feb. 2, in Dubai, United Arab Emirates, highlighting Cedars-Sinai’s expanded global presence and innovative, advanced medical care offered to millions of patients every year.
In a brightly lit kitchen one recent afternoon, cancer survivors Patricia Rhodes and Evette Knight were part of a group gathered around a convection burner and a sauté pan filled with mushrooms. Cancer dietitian Meghan Laszlo, RD, explained why they shouldn’t stir quite yet. “We’re going to try our best to leave them alone so that they brown,” she said.
Cedars-Sinai President and Chief Executive Officer Thomas M. Priselac visited The View Hospital today for a firsthand look at the state-of-the-art facility that will provide the highest-quality care to patients throughout the Gulf Cooperation Council region.
Cardiothoracic surgeons and investigators from the Smidt Heart Institute at Cedars-Sinai bring their leading-edge expertise in heart and lung surgery to the 59th Annual Meeting of The Society of Thoracic Surgeons (STS), Jan. 21-23, 2023, in San Diego.
Martha Gulati, MD, director of Preventive Cardiology and associate director of the Preventive and Rehabilitative Cardiac Center in the Smidt Heart Institute at Cedars-Sinai, has been named the Anita Dann Friedman Endowed Chair in Women’s Cardiovascular Medicine and Research.
Cedars-Sinai has appointed Michael E. Farkouh, MD, MSc, as associate dean for Research and Clinical Trials and professor of Cardiology, effective March 1, 2023. A clinical cardiologist and epidemiologist, Farkouh is internationally known for his academic leadership and distinguished record of diabetes and cardiovascular disease clinical trials.
The Stem Cell and Bone Marrow Transplant Program at Cedars-Sinai Cancer was recently recognized with two important hallmarks of quality: official accreditation for CAR T-cell therapy, and a third year in a row ranking among the top adult bone marrow transplant programs in the U.S.
A new study led by Cedars-Sinai and the University of California, San Francisco (UCSF), has determined that altering a cellular process can lead stem cells—cells from which other cells in the body develop—to die or regenerate.
The U.S. Food and Drug Administration (FDA) recently granted approval to Lecanemab, the first Alzheimer’s disease treatment to win approval since the largely failed rollout of Aduhelm two years ago.
A new analysis by Cedars-Sinai investigators is furthering the scientific community’s understanding of COVID-19 immunity by showing that similar levels of COVID-19 antibodies are reached over an extended period of time in different population groups.
Cedars-Sinai Cancer is taking on the country’s leading cause of cancer-related death with a new Lung Cancer Screening Program designed to reach more patients, simplify the screening process, and provide fast access to follow-up care.
Investigators at Cedars-Sinai have created a unique and detailed molecular profile of endometriosis to help improve therapeutic options for the millions of women suffering from the disease.
The U.S. Food and Drug Administration is poised to make a decision on another new Alzheimer’s disease treatment this week, and experts from the Jona Goldrich Center for Alzheimer’s and Memory Disorders at Cedars-Sinai are available to explain how the drug works and which patients could benefit from the medication.
Peter Heeger, MD, Justin Steggerda, MD, Hirsh Trivedi, MD, and Lorenzo Zaffiri, MD, PhD, have all recently joined the Cedars-Sinai Comprehensive Transplant Center.
Still in the giving spirit as the new year begins? Consider giving blood.
Physicians across the nation are describing an increase in requests from women for permanent contraception. The anecdotal reports by clinicians come in the wake of the U.S. Supreme Court ruling that overturned Roe v. Wade, the constitutional right to abortion.
Buffalo Bills safety Damar Hamlin, 24, remains hospitalized in "critical condition" after experiencing cardiac arrest when he collapsed mid-game against the Cincinnati Bengals on Monday night.
A roundup of the latest medical discoveries and faculty news at Cedars-Sinai.